Skip to main content
. 2023 Dec 15;13(12):6280–6289.

Table 1.

Age-adjusted characteristics of study participants, by case-control status

Characteristic Controls n=375 Cases n=101 P for difference
Mean (SD)
    Age (years)a 52.47 (8.62) 53.92 (8.68) NA
    Age at menarche (years) 12.58 (1.37) 12.27 (1.43) 0.35
    Body Mass Index (kg/m2) 24.77 (4.66) 23.88 (3.73) 0.91
    Age at menopause (years) 49.06 (5.19) 50.15 (2.31) 0.61
    Alcohol, g/day 5.166 (8.78) 3.438 (4.22) 0.83
    CD44 normal TDLU Epithelium % 41.24 (36.58) 38.04 (34.12) 0.13
    CD44 normal TDLU Stroma % 19.09 (27.92) 17.09 (26.4) 0.24
    CD24 normal TDLU Epithelium % 29.32 (23.13) 28.44 (21.54) 0.28
    CD24 normal TDLU Stroma % 9.001 (14.423) 7.122 (9.831) 0.88
    ALDH1A1 normal TDLU Epithelium % 27.21 (19.18) 27.52 (20.84) 0.03
    ALDH1A1 normal TDLU Stroma % 12 (13.8) 12.32 (13.14) 0.29
Percentages
    Parity/age at first birth 0.57
        Nulliparous 9 8
        Parous, age <25 years 50 43
        Parous, age ≥25 years 40 48
    Family history of breast cancer 11 24 0.32
    Benign breast disease 0.18
        Non-proliferative 31 24
        Proliferative without atypia 56 51
        Proliferative with atypia 13 25
    Never smoked 49 36 0.50
    Past smoker 5 6
    Current smoker 13 17
    Premenopausal 40 39 0.82
    Postmenopausal/never used MHT 25 27
    Postmenopausal/past MHT 14 14
    Postmenopausal/current MHT 19 16
a

Value is not age adjusted.